Rephonic
Artwork for OncLive® On Air

OncLive® On Air

OncLive® On Air
Hodgkin's Lymphoma
Chemotherapy
Oncology
Colorectal Cancer
Nivolumab
Onc201
Hepatic Artery Infusion
H3K27M Mutant Diffuse Midline Gliomas
Immunotherapy
CAR T-Cell Therapy
ACTION Trial
Her2-Positive Breast Cancer
Ponatinib
FDA Approval
SWOG 1826
Multiple Myeloma
Siltocaptagine Autolucel
Colorectal Cancer Management
Malignant Perivascular Epithelioid Cell Tumors
Glioma

In OncLive® On Air, you can expect to hear interviews with academic oncologists on the thought-provoking oncology presentations they give at the OncLive® State of the Science Summits. The topics in oncology vary, from systemic therapies, surgery, radiation therapy, to emerging therapeutic approaches in a particular type of cancer. This includes lung cancer, breast cancer, gastrointestinal cancers,... more

PublishesDailyEpisodes500Founded7 years ago
Number of ListenersCategories
Health & FitnessScience

Listen to this Podcast

Artwork for OncLive® On Air

Latest Episodes

In today’s episode, we had the pleasure of speaking with Asad Dean, MD, about treatment selection for patients with chronic lymphocytic leukemia (CLL) in the second-line setting. Dr Dean is a physician at the Texas Oncology-Fort Worth Cancer Center. more

In today’s episode, we had the pleasure of speaking with Alexander Drilon, MD, about the phase 1/2 ARROS-1 trial (NCT05118789) investigating zidesamtinib (NVL-520) in TKI-pretreated patients with advanced ROS1-positive non–small cell lung cancer (NSC... more

In our exclusive interview, Dr Chase discussed the management of recurrent endometrial cancer, emphasizing the importance of biomarker profiles and previous therapies. For first recurrences, she explained that carboplatin and paclitaxel with pembroli... more

In this podcast, experts Aditya Bardia, MD, MPH, FASCO, Erika P. Hamilton, MD, and Virginia Kaklamani, MD, DSc, discuss frequently asked questions regarding the use of antibody-drug conjugates (ADCs) in triple-negative breast cancer (TNBC).

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Recent Guests

Dana M. Chase
MD specializing in oncology, discussing endometrial cancer management.
Episode: S14 Ep18: Patient Characteristics and Disease Factors Guide the Use of Dostarlimab in Recurrent Endometrial Cancer: With Dana M. Chase, MD
Evelyn Y. Wong
Oncologist discussing early onset colorectal cancer.
Episode: S14 Ep15: Cohort Analysis Shows Importance of Early-Onset CRC Awareness and Investigation: With Evelyn Y. Wong, MD
Rita Nanda
Associate Professor of Medicine and Director of the Breast Oncology Program
University of Chicago
Episode: S14 Ep11: Breaking Down the Rationale for Targeting TROP2 in TNBC
Tanya B. Dorff
Medical Doctor specializing in oncology
Episode: S14 Ep5: Safety and Quality-of-Life Considerations Shape ADT Use in Prostate Cancer: With Tanya B. Dorff, MD
Patrick Y. Wen, MD
A prominent academic oncologist discussing the FDA approval of Dordabiprone
Episode: S14 Ep4: FDA Approval Insights: Dordaviprone in H3K27M-Mutated Diffuse Midline Glioma: With Patrick Y. Wen, MD
Bijal Shah, MD, MS
Oncologist with a focus on treatment paradigms for leukemia
Episode: S14 Ep1: Obe-Cel Data Are Poised to Refine and Expand the ALL Treatment Paradigm: With Aaron Logan, MD, PhD; and Bijal Shah, MD, MS
Aaron Logan, MD, PhD
Oncologist with expertise in CAR T-cell therapies
Episode: S14 Ep1: Obe-Cel Data Are Poised to Refine and Expand the ALL Treatment Paradigm: With Aaron Logan, MD, PhD; and Bijal Shah, MD, MS
Masatoshi Kudo
Mentored clinical oncologist specializing in hepatocellular carcinoma
Episode: S13 Ep48: Refining First-Line Immunotherapy Strategies in Hepatocellular Carcinoma: With Masatoshi Kudo, MD, PhD
Hans Lee, MD
Oncologist focusing on bi-specific antibody therapies
Episode: S13 Ep46: FDA Approval Insights: Linvoseltamab in Relapsed/Refractory Multiple Myeloma: With Nisha Joseph, MD; and Hans Lee, MD

Reviews

4.5 out of 5 stars from 30 ratings
  • Best option for CME podcasts

    Love the content! Easily the best platform for listening to CME and staying updated while on the go. Keep up the great work!

    Apple Podcasts
    5
    Dlshaka
    United States3 months ago
  • My favorite podcast for oncology

    This podcast provides excellent information to anyone who works in the medical field on oncology.

    Apple Podcasts
    5
    Chiliman1986
    United States6 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Many appreciate the detailed discussions surrounding the latest research and advancements in cancer treatment.
Listeners praise the insightful content and expert interviews provided, citing it as an excellent resource for oncology professionals.

Top Health & Fitness Podcasts

Talking Points

Recent interactions between the hosts and their guests.

S14 Ep20: The Evolving Role of Noncovalent BTK Inhibition Informs CLL Treatment Selection: With Asad Dean, MD
Q: What could signal that a patient might be ready to move on to pertibutm?
Clinically, signs such as worsening blood counts or progressive lymphadenopathy can indicate that the patient needs to change therapy.
S14 Ep20: The Evolving Role of Noncovalent BTK Inhibition Informs CLL Treatment Selection: With Asad Dean, MD
Q: When making that treatment decision in the second line, is there a role for re-challenge with a covalent BTK inhibitor or BCL2 inhibitor?
He stated that re-challenging a patient who is intolerant to a covalent BTK inhibitor can be possible, particularly after considering resistance mutations.
S14 Ep20: The Evolving Role of Noncovalent BTK Inhibition Informs CLL Treatment Selection: With Asad Dean, MD
Q: Within the chronic lymphocytic leukemia space, how do you approach treatment selection in the second line?
Dr. Dean mentioned the importance of using covalent BTK inhibitors and BCL2 therapy, emphasizing the significance of molecular profiling and NCCN guidelines recommendations.
S14 Ep18: Patient Characteristics and Disease Factors Guide the Use of Dostarlimab in Recurrent Endometrial Cancer: With Dana M. Chase, MD
Q: Can you highlight some of the data that supported the FDA approval for Dostarlimab?
The Ruby trial demonstrated significant improvements in progression-free and overall survival.
S14 Ep18: Patient Characteristics and Disease Factors Guide the Use of Dostarlimab in Recurrent Endometrial Cancer: With Dana M. Chase, MD
Q: How do you determine whether to add chemotherapy to an immunotherapy regimen for patients with recurrent disease?
The decision depends on whether it's the patient's first recurrence and their previous treatments.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About OncLive® On Air

What is OncLive® On Air about and what kind of topics does it cover?

The podcast offers insightful interviews with academic oncologists, focusing on the latest advancements and thought-provoking presentations in the field of oncology. With episodes spanning a wide array of topics including systemic therapies, surgery, and radiation therapy, the discussions cover various cancers like breast, lung, gastrointestinal, hematologic, gynecologic, and genitourinary. Notably, the show highlights emerging therapeutic approaches and ongoing research, creating a valuable resource for healthcare professionals seeking to stay updated on the evolving landscape of cancer treatment.

Where can I find podcast stats for OncLive® On Air?

Rephonic provides a wide range of podcast stats for OncLive® On Air. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to OncLive® On Air and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does OncLive® On Air get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for OncLive® On Air, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for OncLive® On Air?

Rephonic provides comprehensive predictive audience data for OncLive® On Air, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does OncLive® On Air have?

To see how many followers or subscribers OncLive® On Air has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to OncLive® On Air?

These podcasts share a similar audience with OncLive® On Air:

1. Two Onc Docs
2. Oncology Brothers: Practice-Changing Cancer Discussions
3. Oncology Today with Dr Neil Love
4. Research To Practice | Oncology Videos
5. ASCO Guidelines

How many episodes of OncLive® On Air are there?

OncLive® On Air launched 7 years ago and published 500 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact OncLive® On Air?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for OncLive® On Air?

Rephonic pulls ratings and reviews for OncLive® On Air from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for OncLive® On Air?

Rephonic provides full transcripts for episodes of OncLive® On Air. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on OncLive® On Air?

Recent guests on OncLive® On Air include:

1. Dana M. Chase
2. Evelyn Y. Wong
3. Rita Nanda
4. Tanya B. Dorff
5. Patrick Y. Wen, MD
6. Bijal Shah, MD, MS
7. Aaron Logan, MD, PhD
8. Masatoshi Kudo

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days